PILONI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 1.748
AS - Asia 1.465
EU - Europa 1.150
SA - Sud America 278
AF - Africa 82
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.728
Nazione #
US - Stati Uniti d'America 1.679
CN - Cina 429
SG - Singapore 384
VN - Vietnam 241
BR - Brasile 219
RU - Federazione Russa 211
IT - Italia 208
HK - Hong Kong 200
DE - Germania 155
IE - Irlanda 149
FI - Finlandia 114
FR - Francia 94
GB - Regno Unito 66
IN - India 59
ZA - Sudafrica 53
CA - Canada 35
BD - Bangladesh 27
MX - Messico 23
AR - Argentina 21
NL - Olanda 21
PL - Polonia 21
ES - Italia 20
IQ - Iraq 19
AT - Austria 17
SE - Svezia 15
UA - Ucraina 15
CO - Colombia 14
JP - Giappone 13
BE - Belgio 12
ID - Indonesia 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
PH - Filippine 10
PK - Pakistan 10
TR - Turchia 9
CL - Cile 7
SA - Arabia Saudita 7
IL - Israele 6
TN - Tunisia 6
EG - Egitto 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
KH - Cambogia 3
KZ - Kazakistan 3
PA - Panama 3
TH - Thailandia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CH - Svizzera 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
TW - Taiwan 2
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.728
Città #
Singapore 226
San Jose 225
Dallas 204
Ashburn 198
Hong Kong 193
Dublin 149
Beijing 135
Chandler 128
Ho Chi Minh City 85
Munich 73
Los Angeles 63
Hanoi 60
New York 59
Lauterbourg 57
Helsinki 55
Milan 54
Johannesburg 51
Turku 51
Boardman 38
Moscow 38
Pavia 38
Redondo Beach 33
Shanghai 26
Council Bluffs 24
Nanjing 22
Nuremberg 22
Princeton 20
Warsaw 20
Lawrence 19
Orem 19
Jacksonville 17
Medford 16
Shenyang 16
São Paulo 16
Montreal 15
Changsha 14
Chicago 14
Denver 14
Frankfurt am Main 14
Ann Arbor 13
Atlanta 13
Brooklyn 13
Chennai 13
London 13
Nanchang 13
Phoenix 13
Buffalo 12
Falkenstein 12
Jiaxing 12
Mexico City 12
Montesilvano Marina 12
Poplar 12
Tokyo 12
Da Nang 11
Haiphong 11
Rome 11
Santa Clara 11
Stockholm 11
Wilmington 11
Brussels 10
Paris 10
Seattle 9
Vienna 9
Amsterdam 8
Houston 8
Manchester 8
Rio de Janeiro 8
The Dalles 8
Toronto 8
Baghdad 7
Belo Horizonte 7
Brno 7
Columbus 7
Hebei 7
Boston 6
Hải Dương 6
Lyon 6
Madrid 6
Tianjin 6
Washington 6
Cagliari 5
Can Tho 5
Düsseldorf 5
Guangzhou 5
Karachi 5
Porto Alegre 5
Pune 5
Riyadh 5
Biên Hòa 4
Bologna 4
Buenos Aires 4
Curitiba 4
Erbil 4
Fairfield 4
Ha Long 4
Mumbai 4
Nairobi 4
Pittsburgh 4
Portsmouth 4
Quito 4
Totale 3.007
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 158
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 156
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
(1)H NMR To Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification. 143
Assessment and management of pulmonary alveolar proteinosis in a reference center. 136
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 134
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 131
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 128
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 127
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 122
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 119
Asthma-like symptoms: Is it always a pulmonary issue? 112
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 103
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 98
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 98
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 98
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 98
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 95
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 93
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 92
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 87
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 87
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 84
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 82
Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension? 82
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 82
Machine Learning-based Voice Assessment for the Detection of Positive and Recovered COVID-19 Patients 81
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 78
High prevalence of acute stress disorder and persisting symptoms in ICU survivors after COVID-19 77
Phenotyping sarcoidosis: a single institution retrospective analysis 75
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 75
Phenotypes and Serum Biomarkers in Sarcoidosis 74
COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining 71
A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP) 69
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 67
Predictive markers associated to fibrotic evolution in hypersensitivity pneumonitis: a single institution's analysis 67
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 66
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review 65
Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience 63
Risk stratification in patients with residual pulmonary hypertension after pulmonary endarterectomy 61
Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD 61
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 59
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 57
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 56
Study of acceptance/rejection mechanisms in lung allograft recipients and development of a new therapeutic approach based on nanotechnology 55
Inhaled corticosteroids and risk of osteoporosis in late-middle age subjects: a multicenter European cohort study 54
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 52
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 52
Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study 51
BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance. 38
Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study 37
Right single lung transplantation or double lung transplantation compared with left single lung transplantation in chronic obstructive pulmonary disease 35
Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation 34
Lung tumors, COPD and immune response: is epigenetics the bottom line? 32
Lymph-node mapping in lung cancer staging: accuracy and limits of the current approaches 29
Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients 26
Exploring adjuvant epidermal growth factor receptor inhibition in non-small cell lung cancer 23
Quantitative analysis of airway obstruction in lymphangioleiomyomatosis 20
Totale 4.826
Categoria #
all - tutte 19.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 7 1 2
2021/202286 3 1 3 0 1 1 0 5 7 4 13 48
2022/2023387 40 36 7 29 25 32 0 15 175 2 19 7
2023/2024315 44 53 14 15 47 57 16 20 5 15 8 21
2024/20251.225 31 31 45 48 30 128 73 74 296 69 134 266
2025/20262.555 220 145 307 344 362 88 499 127 309 154 0 0
Totale 4.826